Our mission is to present users with ubiquitous, real-time guidance on the wellness impact of air quality on their daily lives - even at low levels.
About
Zonegard specialises in next-generation, personalised air quality monitoring (“AQM”) solutions embedded within smart devices. Our mission is to present users with ubiquitous, real-time guidance on the wellness impact of air quality on their daily lives - even at very low levels. The issue of air quality is barely out of the news. In January 2016, the WHO stated that air pollution had become a global "public health emergency". Historically, chronic low level exposure to poor air quality has been ignored because of the inability to interpret the data meaningfully for users. Hence, the current generation of AQM devices are designed to monitor (and alarm!) only for acute levels of air pollutants. This is despite clear evidence of poor air quality in homes, workplaces or even vehicles (carbon monoxide, for example, may exceed WHO guideline thresholds in as many as 50% of cases). Furthermore, no account is taken of the individual’s 'personal' health characteristics or even the user's activity or context while being monitored. The result is a significant disconnect between the deep public concern for poor air quality – and the availability of intelligent, appealing solutions to guide users in optimising air quality and wellness in their lives. Through exclusive and patented functionality, Zonegard is uniquely placed to lead a new generation of intelligent, personalised AQM markets for a multitude of applications. Key patent claims concern: Personalisation – i.e.,the ability to personalise the evaluation of harm thresholds, operational modes and countdowns on the basis of the user’s age, sex, weight, activity or health Wellness Countdowns – i.e.,the ability to interpret air quality data for users with a calculated ‘wellness’ impact and projected time frame Context sensitivity – i.e.,the ability to intelligently adapt monitoring or notification modes to the users’ proximity or activity As of April 2016, Zonegard enjoys a patent footprint of over 1.2 billion potential users with granted patents in the US (2) and China. EU patent applications are pending.